 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | ATPase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (-)-Blebbistatin | 99%+ | ||||||||||||||||||
| PF 03716556 | ++++ H+/K+-ATPase, pIC50: ~6.5 | 99% | |||||||||||||||||
| Esomeprazole sodium | ✔ | 98% | |||||||||||||||||
| BTB06584 | ✔ | 99% | |||||||||||||||||
| Ciclopirox | ✔ | 97% | |||||||||||||||||
| CB-5083 | ++++ p97 AAA ATPase, IC50: 11 nM | 99%+ | |||||||||||||||||
| Ciclopirox olamine | ✔ | 99% | |||||||||||||||||
| Brefeldin A | +++ ATPase (HCT 116), IC50: 0.2 μM | 99%+ | |||||||||||||||||
| Oligomycin A | ✔ | 99% | |||||||||||||||||
| Sodium orthovanadate | +++ (Na,K)-ATPase, IC50: 40 nM | 25-28%V | |||||||||||||||||
| Golgicide A | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| Concentration | Treated Time | Description | References | |
| WM983B | 0.0457-100μM | 96 hours | TTM reduced the number of viable WM983B cells in a dose-dependent manner | Cancer Res. 2020 Apr 1;80(7):1387-1400. | 
| 451-Lu | 0.0457-100μM | 96 hours | TTM reduced the number of viable 451-Lu cells in a dose-dependent manner | Cancer Res. 2020 Apr 1;80(7):1387-1400. | 
| WM88 | 0.0457-100μM | 96 hours | TTM reduced the number of viable WM88 cells in a dose-dependent manner | Cancer Res. 2020 Apr 1;80(7):1387-1400. | 
| A375 | 0.0457-100μM | 96 hours | TTM reduced the number of viable A375 cells in a dose-dependent manner | Cancer Res. 2020 Apr 1;80(7):1387-1400. | 
| Administration | Dosage | Frequency | Description | References | ||
| SCID/beige mice | Subcutaneous xenograft model | Oral gavage | 80 mg/kg | Daily for 30 days | TTM alone or in combination with ABT-263 significantly suppressed tumor growth | Cancer Res. 2020 Apr 1;80(7):1387-1400. | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 4.46mL 0.89mL 0.45mL | 22.30mL 4.46mL 2.23mL | 44.60mL 8.92mL 4.46mL | |
| CAS号 | 16330-92-0 | 
| 分子式 | MoS4 | 
| 分子量 | 224.2 | 
| SMILES Code | [S-][Mo]([S-])(=S)=S | 
| 别名 | |
| 运输 | 蓝冰 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, room temperature | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1